Expert Details
Tobacco Control, Public Health, Epidemiology, Health Psychology, Quantitative Analysis
ID: 728522
United Kingdom
Expert's strengths:
-Interview regarding the results and feasibility of novel smoking cessation therapy, its barriers to market entry and expected reception of product as well as general overview of future tobacco control developments
-Provision of feedback on tobacco control conference
-Preparation and writing of systematic review evaluating effectiveness of online support for smoking cessation to inform new guidance document
-Writing and delivering of presentation about clinical trial results of a new smoking cessation therapy (Varenicline Tartrate/ Champix/ Chantix) compared with existing behavioral and pharmacological therapy for German Congress of Respiratory Physicians
-Development of clinical framework and toolkit for smoking cessation treatment for patients receiving pharmacological treatment for Rheumatology and Crohn's disease.
-Writing of evidence summaries/briefings for health professionals on multiple clinical questions for smoking cessation treatment for the National Centre for Smoking Cessation Training
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 2010 | Degree: MSc | Subject: Neuroscience | Institution: University College London |
| Year: 2008 | Degree: PhD | Subject: Epidemiology and Health Psychology | Institution: University of London |
| Year: 2004 | Degree: MSc | Subject: Health Psychology | Institution: Instititute of Psychiatry, King's College London |
| Year: 2003 | Degree: MA | Subject: Psychology, Philosophy and Physiology | Institution: University of Oxford |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 2007 to Present | Employer: Undisclosed | Title: Associate Professor | Department: Epidemiology and Public Health |
Responsibilities:His responsibilities involve: analyses of large scale data sets, dissemination of research findings through publications, conferences and other public engagements; seeking of research grant funding; setting-up, running and co-ordination of research projects and clinical trials; initiation and maintenance of national as well as international research collaborations; supervision and teaching of students. |
|||
Government Experience
| Years | Agency | Role | Description |
|---|---|---|---|
| Years: 2006 to 2006 | Agency: Centers of Disease Control, USA | Role: Freelancer | Description: Study to investigate level of exposure of smokers to Tobacco-specific nitrosamines; involved development of recruitment strategy, interviewing and collecting samples from participants as well as data interpretation and analysis. |
| Years: 2007 to 2007 | Agency: National Institute of Clinical Excellence, UK | Role: Freelancer | Description: Writing of expert guidance - responsible for designing data extraction and classification forms, also assisted in the development and evaluation of the search strategy, collation of study data and writing of a systematic review. |
| Years: 2007 to 2007 | Agency: Department of Health, UK | Role: Freelancer | Description: Study to evaluate carcinogen exposure among smokers - helped to design and to obtain funding and ethical approval for research project; also instrumental in setting up and running of study, including administrative management and data analysis. |
| Years: 2008 to 2008 | Agency: National Health Service, UK | Role: Freelancer | Description: He helped to communicate new smoking cessation guidance to dental teams across the UK by composing required material (memos, letters, powerpoint presentation) |
| Years: 2018 to 2018 | Agency: UK Parliamient | Role: Researcher | Description: Expert witness for inquiry into e-cigarettes |
International Experience
| Years | Country / Region | Summary |
|---|---|---|
| Years: 2006 to 2006 | Country / Region: USA, Canada | Summary: Visit to laboratories in USA (New York) and Canada (Waterloo) to share experience, knowledge and further international collaboration |
| Years: 2007 to 2007 | Country / Region: Germany | Summary: Presentation of data on varenicline effectiveness for Pfizer |
| Years: 2012 to Present | Country / Region: Hong Kong | Summary: Expert reviewer for Food and Health Bureau |
| Years: 2014 to Present | Country / Region: France | Summary: Advisory Panel for Cancer Institute |
| Years: 2017 to Present | Country / Region: Sweden / US | Summary: Advisory Panel for Johnson & Johnson |
| Years: 2018 to 2018 | Country / Region: Switzerland | Summary: Presentation and report writing for Swiss Tropical and Public Health Institute |
Career Accomplishments
| Associations / Societies |
|---|
| Associate Fellow of the British Psychological Society Full Member of the Division of Health Psychology Associate Fellow of the Higher Education Academy Member of the Society for Research on Nicotine and Tobacco Member of the European Health Psychology Society Member of the Federation of European Neuroscience Societies |
| Licenses / Certifications |
|---|
| Postgraduate Certificate for Learning and Teaching in Higher Education; Trained smoking cessation counselor; Stage II qualified Health Psychologist |
| Professional Appointments |
|---|
| 2016-present Section Editor, treatobacco.net 2015-present Senior Editor, Addiction 2014-present Editor, Smoking in Britain 2013-present Academic Editor, PLOS One 2009-present Assistant Editor, Addiction |
| Awards / Recognition |
|---|
| Various educational and career development scholarships (Medical Research Council, Employer, NIH) |
| Medical / Professional |
|---|
| Non-practising qualified Health Psychologist (2012 onwards). |
| Publications and Patents Summary |
|---|
| He has published 83 peer-reviewed articles and 24 book chapters and reports. |
Additional Experience
| Expert Witness Experience |
|---|
| Expert advice to National Institute of Clinical Excellence and Department of Health (UK) on Tobacco Control Policies. Provided expert witness testimony to Houses of Parliament on inquiry into e-cigarettes. Am currently on steering committees for several ongoing trials into pharmacotherapy effectiveness for smoking cessation. |
| Training / Seminars |
|---|
| Teaching of epidemiological statistics to medical students, provision of public health seminars to masters students and health psychology teaching to undergraduates. Development of teaching material for the National Health Service on new smoking cessation guidance; Programme lead for MSc in Health Psychology |
| Vendor Selection |
|---|
| Identification of laboratories for the analysis of biomarkers of exposure to nicotine (cotinine) as well as carcinogens (TSNAs, PAH). |
| Marketing Experience |
|---|
| General expertise in field of Tobacco Control, e.g. current developments in pharmacological smoking cessation interventions, attitude in population towards tobacco control strategies, smoking and smoking-related disease prevalence and time trends. |
| Other Relevant Experience |
|---|
| Experience of conference organisation (e.g. Scientific Organizing Committee for SRNT-E conference in Prague) |
Language Skills
| Language | Proficiency |
|---|---|
| English | He is highly proficient |
| German | Mother tongue |
Fields of Expertise
toxicology risk assessment, nicotine, cigarette smoke, public health epidemiology, smoking, smoking human health effect, survey statistics, tobacco smoke, tobacco smoke human health effect, tobacco control, behavioral medicine, addiction, public health psychiatry, addiction psychiatry, psychology research, design of experiments, medical statistics, psychology, statistical data analysis, preventive medicine, epidemiology